Cập nhật tin tức quốc tế

Tin tức Y tế

Cập nhật tin tức quốc tế

137 Tin tức Y tế
Cập nhật tin tức quốc tế New Eye Drops Show Promise for Treating Presbyopia
New Eye Drops Show Promise for Treating Presbyopia

Researchers estimate that about 1.8 billion people around the world live with presbyopia, a farsight...

Cập nhật tin tức quốc tế Vitamin D Overdose: When Good Intentions Turn Toxic
Vitamin D Overdose: When Good Intentions Turn Toxic

Vitamin D is essential for calcium absorption and bone health

Cập nhật tin tức quốc tế Lenacapavir: A Game-Changer in HIV Prevention with FDA Approval and WHO Support
Lenacapavir: A Game-Changer in HIV Prevention with FDA Approval and WHO Support

FDA approval of injectable lenacapavir marks progress for HIV prevention

Cập nhật tin tức quốc tế AZURE-1 will evaluate the efficacy and safety of brelovitug compared to delayed treatment
AZURE-1 will evaluate the efficacy and safety of brelovitug compared to delayed treatment

Hepatitis D Overview: Clinical Data Update & Practical Implications

Cập nhật tin tức quốc tế Methotrexate Boosts Steroid-Free Remission in Newly Diagnosed Polymyalgia Rheumatica
Methotrexate Boosts Steroid-Free Remission in Newly Diagnosed Polymyalgia Rheumatica

Compared with placebo, adding methotrexate (MTX) to treatment for newly diagnosed polymyalgia rheuma...

Cập nhật tin tức quốc tế Muscle Gains vs Heart Strain: A Deadly Trade-off?
Muscle Gains vs Heart Strain: A Deadly Trade-off?

A global study of more than 20,000 athletes is the first to report the incidence of sudden death in...

Cập nhật tin tức quốc tế Nivolumab Plus Chemotherapy Before Surgery Improves Survival in Lung Cancer
Nivolumab Plus Chemotherapy Before Surgery Improves Survival in Lung Cancer

Adding nivolumab to neoadjuvant chemotherapy significantly improved 5-year overall survival among pa...

Cập nhật tin tức quốc tế New 4-Drug Combination Offers New Hope for People with Newly Diagnosed Multiple Myeloma
New 4-Drug Combination Offers New Hope for People with Newly Diagnosed Multiple Myeloma

A new treatment approach for multiple myeloma, a serious blood cancer, has shown very promising resu...

Cập nhật tin tức quốc tế Sacituzumab Govitecan + Pembrolizumab: A New First-Line Standard in PD-L1-Positive Metastatic TNBC
Sacituzumab Govitecan + Pembrolizumab: A New First-Line Standard in PD-L1-Positive Metastatic TNBC

Sacituzumab Govitecan + Pembrolizumab: A New First-Line Standard in PD-L1-Positive Metastatic TNBC